Legendary Investments PLC Authorities to Operate Granted to IBS (8085L)
23 Aprile 2018 - 2:46PM
UK Regulatory
TIDMLEG
RNS Number : 8085L
Legendary Investments PLC
23 April 2018
23 April 2018
Legendary Investments PLC
("Legendary" or the "Company")
Authorities to Operate Granted to IBS
Legendary is pleased to announce that IBS, the operating
subsidiary of IBS Corporation Limited ("IBS Corp"), has been
granted authorities to operate by the New Zealand regulatory
authorities.
IBS is now able to establish its banking services platform with
the ability to provide a range of financial services including
investment banking, asset management and debt services tailored to
corporate and high net worth clients.
The availability of investment banking, asset management and
debt services to New Zealand SMEs is less well developed than in
international markets. IBS is targeting opportunities in this area,
providing debt funding and taking equity stakes in New Zealand
SMEs. Target sectors include fintech, property and horticulture,
agriculture and fisheries.
While awaiting the authorities to operate, IBS Corp has scoped
several potential transactions in the fintech and property sectors.
These transactions range in size from a few million dollars to
several hundred million dollars plus. Following the granting of
authorities to operate, work on these transactions will commence.
IBS Corp has also identified several sources of funding lines for
its business. IBS will not be taking deposits from the public nor
will it be issuing debt securities in New Zealand.
Additionally, IBS Corp has identified a core group of
professionals with international and New Zealand banking and
financial sector experience to drive growth.
Further announcements will be made as appropriate.
Zafar Karim, Executive Chairman of Legendary, said:
"We are delighted that IBS has been granted the authorities to
operate. Legendary was involved with IBS Corp from its
establishment. In November 2017, following debt to equity
conversions and further equity investments, IBS Corp was valued at
US$10 million, increasing the value of Legendary's stake, acquired
at nominal value, to US$1.1 million.
"Now that authorities to operate have been granted, IBS can
commence providing services as a 'challenger' financial services
platform, initially focussing in New Zealand and with ambitions to
expand further into the most dynamic regions in the world. IBS
expects to grow its business and create value rapidly. Importantly,
the activities of IBS are complementary to the activities of
Legendary thereby providing further opportunities for value
generation."
- ENDS -
Legendary Investments Zafar Karim / Thomas
PLC Reuner 020 8201 3536
Grant Thornton Colin Aaronson
UK LLP / Harrison Clarke 020 7383 5100
S.P. Angel Corporate
Finance LLP Richard Morrison 020 3470 0504
The information contained within this announcement is deemed to
constitute inside information as stipulated under the Market Abuse
Regulations (EU) No. 596/2014. Upon the publication of this
announcement, this inside information is now considered to be in
the public domain.
About Legendary Investments PLC
Legendary Investments PLC is a proactive investment company that
focuses on making investments in and assisting companies which
exhibit the potential to generate returns of many multiples through
capital appreciation. Typically, Legendary invests in small
companies where there are clear catalysts for value appreciation
and the companies are operating in sectors exhibiting long term
growth. Examples of such sectors include technology, energy and
natural resources.
www.leginvest.com
This information is provided by RNS
The company news service from the London Stock Exchange
END
MSCDMGZDZFDGRZM
(END) Dow Jones Newswires
April 23, 2018 08:46 ET (12:46 GMT)
Grafico Azioni Legendary Inv. (LSE:LEG)
Storico
Da Gen 2025 a Feb 2025
Grafico Azioni Legendary Inv. (LSE:LEG)
Storico
Da Feb 2024 a Feb 2025